These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32092415)

  • 1. Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Pisapia R; Gärtner B; Berger FK; Reigadas E; Bouza E; Demont C; Wilcox MH
    Anaerobe; 2020 Apr; 62():102178. PubMed ID: 32092415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID).
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Wilcox MH
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1949-1956. PubMed ID: 27590621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of
    Colomb-Cotinat M; Assouvie L; Durand J; Daniau C; Leon L; Maugat S; Soing-Altrach S; Gateau C; Couturier J; Arnaud I; Astagneau P; Berger-Carbonne A; Barbut F
    Euro Surveill; 2019 Aug; 24(35):. PubMed ID: 31481147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of molecular testing on reported
    Ilieş I; Benneyan JC; Jabur TBC; Baker AW; Anderson DJ
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):306-312. PubMed ID: 31852562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.
    Xuan S; Zangwill KM; Ni W; Ma J; Hay JW
    J Gen Intern Med; 2020 Apr; 35(4):1102-1110. PubMed ID: 32016703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.
    Kato H; Senoh M; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
    Anaerobe; 2019 Dec; 60():102011. PubMed ID: 30872073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections.
    Cook PP; Nichols S; Coogan M; Opera J; DeHart M
    Am J Infect Control; 2020 Sep; 48(9):1019-1022. PubMed ID: 32044135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
    Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA
    PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset
    McCormick WL; Jackson G; Andrea SB; Whitehead V; Chargualaf TL; Touzard-Romo F
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):106-109. PubMed ID: 37424227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model.
    Agnew E; Davies KA; Viprey VF; Evans S; Davis GL; Hope R; Wilcox MH; Wingen-Heimann SM; Robotham JV;
    Clin Microbiol Infect; 2023 Jun; 29(6):796.e1-796.e6. PubMed ID: 36773769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and trends of Clostridioides difficile infections in hospitalized patients: a prospective multi-centre cohort study in six German university hospitals, 2016-2020.
    Jazmati N; Mischnik A; Kern WV; Behnke M; Chakraborty T; Dinkelacker A; Eisenbeis S; Falgenhauer J; Gastmeier P; Häcker G; Imirzalioglu C; Käding N; Kramme E; Peter S; Piepenbrock E; Rupp J; Schneider C; Schwab F; Seifert H; Tacconelli E; Trauth J; Biehl L; Walker SV; Rohde AM;
    J Hosp Infect; 2024 Sep; 151():161-172. PubMed ID: 38969208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Antibiotic Consumption and Incidence of
    Kim B; Kim J; Pai H
    J Korean Med Sci; 2020 Dec; 35(47):e407. PubMed ID: 33289370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chasing the rate: An interrupted time series analysis of interventions targeting reported hospital onset
    Doll ME; Zhao J; Kang L; Rittmann B; Alvarez M; Fleming M; Cooper K; Stevens MP; Bearman G
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1142-1147. PubMed ID: 32493530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to: Surveillance of Clostridium difficile infections.
    Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ;
    Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinates of
    Fridkin SK; Onwubiko UN; Dube W; Robichaux C; Traenkner J; Goodenough D; Angulo FJ; Zamparo JM; Gonzalez E; Khanna S; Myers C; Dumyati G
    Infect Control Hosp Epidemiol; 2023 Jul; 44(7):1085-1092. PubMed ID: 36102331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.
    Schultz K; Sickbert-Bennett E; Marx A; Weber DJ; DiBiase LM; Campbell-Bright S; Bode LE; Baker M; Belhorn T; Buchanan M; Goldbach S; Harden J; Hoke E; Huenniger B; Juliano JJ; Langston M; Ritchie H; Rutala WA; Smith J; Summerlin-Long S; Teal L; Gilligan P
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29997201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing
    Magro M; Rosenberg J; Epson E
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):292-297. PubMed ID: 32993820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.